$NTLA news
The latest NTLA stock news: headlines, filings, AI summaries and sentiment for $NTLA, updated around the clock.
- Intellia Therapeutics, Inc. - 10-Q Filing
- Intellia Therapeutics, Inc. - 8-K Filing
- Cathie Wood's Ark Invest Increases Holdings in Nvidia and Intellia
- Intellia Therapeutics' Lonvo-z Nears Regulatory Approval in 2027
- Intellia Prepares for Potential Launch of Lonvo-z as FDA Decision Nears
- Intellia Therapeutics, Inc. - 8-K Filing
- Intellia Therapeutics Receives FDA Priority Review for Lonvoz
- Intellia Therapeutics, Inc. - 8-K Filing
- Intellia Therapeutics Secures $400M Loan Facility
- ARK Invest's Q2 2026 Portfolio Update: $15.4B in Assets with Focus on Disruptive Innovation
- Wall Street Increases Short Positions on Wolfspeed Amid Cash Burn Concerns
- Intellia Therapeutics Shares Rise on Positive Lonvo-Z Trial Results
- Intellia Therapeutics, Inc. - 10-Q Filing
- Cathie Wood's Ark Invest Adds to Positions in Shopify, Intellia Therapeutics, and GeneDX
- Intellia Therapeutics Prices $180M Stock Offering at Discount
- Intellia Therapeutics' Crispr-based treatment shows success in pivotal trial for hereditary angioedema